Bafna Pharmaceuticals
add_icon

Bafna Pharmaceuticals

176.34
+16.03
(10.00%)
Market Cap
417.16 Cr
PE Ratio
-
Volume
8,913.00
Day High - Low
176.34 - 169.00
52W High-Low
202.06 - 72.01
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
417.16 Cr
EPS
-15.52
PE Ratio
-
PB Ratio
7.52
Book Value
40.64
EBITDA
1.50
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
-3.68
Debt to Equity
0.70
Forecast For
Actual

Company News

View All News
Caret
positive
Bafna Pharmaceuticals reported a net profit of ₹1,109.98 lakh for FY26, up from ₹415.25 lakh in the previous year. Revenue from operations increased to ₹15,061.74 lakh.
neutral
SRJR Lifesciences LLP, promoter of Bafna Pharmaceuticals Ltd, confirmed no encumbrance on shares held during FY26. The disclosure was made to BSE and NSE under SEBI regulations.
neutral
Bafna Pharmaceuticals board meets on May 29, 2026, to consider audited financial results for FY26. Trading window closed from April 1 to May 31.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,782.20
#1 4,27,609.48
37.09
#1 58,220.10
6.38
#1 11,565
25.80
43.33
6,623.00
1,75,819.84
68.17
10,560.00
8.73
2,520
13.44
49.66
4,420.90
1,49,623.34
68.66
13,886.20
20.34
2,138
-26.91
53.32
1,401.30
1,13,194.31
29.24
27,711.70
-2.46
3,783
-55.32
58.57
1,089.00
1,09,578.88
21.32
26,719.70
13.65
5,242
7.82
71.01
1,278.20
1,06,684.07
25.44
33,593.30
-0.44
3,998
-86.05
45.82
2,267.70
1,03,643.69
#1 19.20
27,487.50
19.98
5,345
#1 87.72
47.04
2,336.10
96,435.39
50.16
14,277.60
12.03
1,750
31.75
47.08
1,462.30
84,930.62
24.27
33,384.70
3.21
3,376
1.99
53.78
1,446.80
78,106.45
86.55
6,812.90
#1 21.03
884
21.18
80.98
Growth Rate
Revenue Growth
-2.95 %
Net Income Growth
-90.21 %
Cash Flow Change
-1,816.76 %
ROE
-96.42 %
ROCE
-90.07 %
EBITDA Margin (Avg.)
-112.00 %

Quarterly Financial Results

Quarterly Financials
Jun 2018
Sept 2018
Jun 2019
Sept 2019
Revenue
12
9
7
12
Expenses
14
9
10
12
EBITDA
-2
0
-3
0
Operating Profit %
-15 %
2 %
-42 %
-3 %
Depreciation
1
1
1
1
Interest
1
1
0
0
Profit Before Tax
-4
-1
-4
-1
Tax
0
0
-2
0
Net Profit
-4
-1
-2
-1
EPS in ₹
0.00
-0.80
-0.90
-0.25

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
Total Assets
200
193
178
138
120
71
Fixed Assets
55
53
49
45
37
35
Current Assets
127
123
77
49
49
36
Capital Work in Progress
0
0
0
0
0
0
Investments
0
0
17
0
0
0
Other Assets
145
140
113
94
82
36
Total Equity & Liabilities
200
193
178
138
120
71
Current Liabilities
111
95
82
60
71
17
Non Current Liabilities
16
40
55
41
30
3
Total Equity
73
58
42
37
19
51
Reserve & Surplus
53
39
20
14
-5
-7
Share Capital
19
19
19
24
24
2

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
Net Cash Flow
0
-0
-0
0
-0
6
Investing Activities
60
-0
-5
38
15
33
Operating Activities
11
1
-1
-7
-2
-34
Financing Activities
-71
-1
6
-31
-14
7

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Promoter
91.74 %
90.39 %
90.40 %
90.42 %
90.42 %
90.12 %
90.00 %
90.02 %
90.00 %
90.00 %
88.74 %
88.43 %
88.30 %
88.30 %
88.30 %
88.30 %
75.00 %
75.00 %
75.00 %
75.00 %
75.00 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
8.53 %
9.34 %
9.34 %
9.34 %
9.34 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
6.31 %
6.23 %
6.26 %
6.10 %
5.24 %
5.50 %
5.62 %
5.61 %
5.64 %
5.64 %
6.87 %
7.66 %
7.48 %
7.37 %
7.69 %
7.66 %
11.06 %
11.62 %
12.03 %
12.13 %
12.13 %
Others
1.95 %
3.37 %
3.34 %
3.49 %
4.33 %
4.38 %
4.38 %
4.37 %
4.37 %
4.36 %
4.39 %
3.91 %
4.23 %
4.34 %
4.01 %
4.04 %
5.40 %
4.04 %
3.63 %
3.53 %
3.53 %
No of Share Holders
8,603
8,330
8,068
7,910
7,326
7,223
7,275
7,199
7,120
6,992
7,354
7,367
7,539
7,391
7,295
7,214
7,142
7,283
7,572
7,119
6,928

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
25 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
25 Sept 2024 82.30 80.11
11 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Nov 2024 80.13 81.90
06 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Feb 2025 77.43 78.02
26 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
26 May 2025 76.88 73.00
12 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Aug 2025 83.14 91.46
19 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
19 Sept 2025 91.46 130.85
11 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Nov 2025 170.25 192.35
11 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Feb 2026 119.90 128.00
29 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
29 May 2026 138.36 134.50

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication4 days ago
Audited Financial Results For Quarter And Year Ended March 31 20267 days ago
Board Meeting Outcome for Outcome Of The Board Meeting Held On May 29 20267 days ago
Board Meeting Intimation for Meeting Scheduled On May 29 2026May 21, 2026
Clarification On Price MovementApr 15, 2026
Clarification sought from Bafna Pharmaceuticals LtdApr 13, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 13, 2026
Board Meeting Outcome for Outcome For Board Meeting Held On 27/03/2026Mar 27, 2026
Closure of Trading WindowMar 26, 2026
Clarification On Price MovementMar 24, 2026
Clarification sought from Bafna Pharmaceuticals LtdMar 23, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 14, 2026
Unaudited Financial Results For The Quarter And Nine Months Ended On December 31 2025Feb 11, 2026
Board Meeting Outcome for Outcome For The Board Meeting Held On 11/02/2026Feb 11, 2026
Board Meeting Intimation for Meeting Scheduled On February 11 2026Feb 05, 2026
Announcement under Regulation 30 (LODR)-Credit RatingJan 23, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 09, 2026
Closure of Trading WindowDec 26, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 14, 2025
Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025Nov 11, 2025
Board Meeting Outcome for Outcome For The Board Meeting Held On 11/11/2025Nov 11, 2025
Board Meeting Intimation for Meeting Scheduled On November 11 2025Nov 06, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 10, 2025
Closure of Trading WindowSep 26, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementSep 19, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateSep 19, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 19, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 28, 2025
Notice Of 30Th Annual General Meeting Of The Company For The F.Y 2024-2025Aug 26, 2025
Reg. 34 (1) Annual Report.Aug 26, 2025
Book Closure For 30Th Annual General Meeting (AGM)Aug 21, 2025
Shareholder Meeting - 30Th AGM On September 19 2025Aug 21, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 14, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateAug 12, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementAug 12, 2025
Unaudited Financial Results For The Quarter Ended June 30 2025Aug 12, 2025
Board Meeting Outcome for Outcome For The Board Meeting Held On 12/08/2025Aug 12, 2025
Board Meeting Intimation for Meeting Scheduled On August 12 2025Aug 07, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 05, 2025
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015Jun 30, 2025
Closure of Trading WindowJun 26, 2025
Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Re-Constitution Of CommitteesJun 24, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateJun 24, 2025
Announcement under Regulation 30 (LODR)-RetirementJun 24, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJun 23, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateJun 23, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 30, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2025
Audited Financial Results For The Quarter & Year Ended March 31 2025May 26, 2025
Board Meeting Outcome for Outcome For The Board Meeting Held On 26/05/2025May 26, 2025

Technical Indicators

RSI(14)
Neutral
75.12
ATR(14)
Less Volatile
7.22
STOCH(9,6)
Neutral
74.32
STOCH RSI(14)
Overbought
100.00
MACD(12,26)
Bullish
2.08
ADX(14)
Weak Trend
20.04
UO(9)
Bearish
58.03
ROC(12)
Uptrend And Accelerating
18.48
WillR(14)
Overbought
0.00